CX Institutional increased its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 8.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 4,539 shares of the company’s stock after buying an additional 340 shares during the period. CX Institutional’s holdings in Colgate-Palmolive were worth $413,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also bought and sold shares of CL. FMR LLC increased its stake in shares of Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after purchasing an additional 2,674,807 shares during the period. Barclays PLC grew its holdings in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares in the last quarter. State Street Corp increased its position in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the period. Nordea Investment Management AB grew its stake in shares of Colgate-Palmolive by 32.5% in the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after acquiring an additional 1,247,731 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its position in Colgate-Palmolive by 864.1% during the third quarter. Jacobs Levy Equity Management Inc. now owns 777,854 shares of the company’s stock worth $80,749,000 after acquiring an additional 697,168 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.
Insider Buying and Selling
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.34% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on CL
Colgate-Palmolive Stock Performance
Shares of Colgate-Palmolive stock opened at $87.88 on Friday. The stock has a market cap of $71.79 billion, a price-to-earnings ratio of 25.18, a P/E/G ratio of 3.59 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a twelve month low of $80.03 and a twelve month high of $109.30. The company’s fifty day moving average is $91.81 and its 200 day moving average is $97.44.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. Colgate-Palmolive’s payout ratio is 57.31%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Stock Average Calculator
- Bloom Energy: Powering the Future With Decentralized Energy
- Which Wall Street Analysts are the Most Accurate?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- 3 Tickers Leading a Meme Stock Revival
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.